Article

What is the role of genetics in occupational asthma?

Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Ferrara, Via Fossato di Mortara 64 B, 44100 Ferrara, Italy. .
European Respiratory Journal (Impact Factor: 7.13). 04/2009; 33(3):459-60. DOI: 10.1183/09031936.00183508
Source: PubMed
0 Followers
 · 
68 Views
 · 
0 Downloads
  • Source
    • "Overall, the currently available information indicates that genetic testing is limited for both diagnostic and preventive purposes.98 It is unknown why one gene may represent a risk factor in some populations, but not in others. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this article is to critically review the available evidence pertaining to occupational, environmental, and individual factors that can affect the development of occupational asthma (OA). Increasing evidence suggests that exploration of the intrinsic characteristics of OA-causing agents and associated structure-activity relationships offers promising avenues for quantifying the sensitizing potential of agents that are introduced in the workplace. The intensity of exposure to sensitizing agents has been identified as the most important environmental risk factor for OA and should remain the cornerstone for primary prevention strategies. The role of other environmental co-factors (e.g., non-respiratory routes of exposure and concomitant exposure to cigarette smoke and other pollutants) remains to be further delineated. There is convincing evidence that atopy is an important individual risk factor for OA induced by high-molecular-weight agents. There is some evidence that genetic factors, such as leukocyte antigen class II alleles, are associated with an increased risk of OA; however, the role of genetic susceptibility factors is likely to be obscured by complex gene-environment interactions. OA, as well as asthma in general, is a complex disease that results from multiple interactions between environmental factors and host susceptibilities. Determining these interactions is a crucial step towards implementing optimal prevention policies.
    Allergy, asthma & immunology research 07/2011; 3(3):157-67. DOI:10.4168/aair.2011.3.3.157 · 3.08 Impact Factor
  • Source
    • "After adjusting for age, gender, and other ADRB2 SNPs, the ht1 [TTACGC] haplotype, composed of all wild genotypes of Arg16Gly, Leu134Leu, and Arg175Arg among the six ADRB2 SNPs, was significantly associated with specific IgE sensitization in TDI-exposed workers. Additional environmental factors, including inhaled aeroallergen exposure, smoking, and viral infections, must undergo further evaluation.37 Therefore, further studies are required to evaluate the associations between ADRB2 polymorphisms and TDI-OA pathogenesis and to better elucidate the complex interactions of ADRB2 polymorphisms with environmental or genetic factors that may increase TDI-OA susceptibility. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A genetic polymorphism of the beta 2-adrenergic receptor is a major factor associated with the asthmatic phenotype. The association of this polymorphism with toluene diisocyanate (TDI)-induced asthma has not been investigated. We examined 103 TDI-induced asthma patients (TDI-OA), 60 asymptomatic exposed controls (AEC), and 263 unexposed healthy controls (NC) in order to identify beta 2-adrenergic receptor gene (ADRB2) polymorphisms and the possible association with TDI-induced asthma. Single nucleotide polymorphisms (SNPs) of ADRB2 were genotyped by direct sequencing. Serum-specific IgE and IgG levels were measured using an enzyme-linked immunosorbent assay. Phenotypes and clinical patient parameters were compared. SNPs were identified (-47 T>C, -20 T>C, Arg16Gly A>G, Gln27Glu C>G, Leu134Leu G>A, Arg175Arg C>A) during ADRB2 screening (from -231 to 793 bp). No significant differences in allelic and genotypic frequencies were noted for any of the six ADRB2 SNPs. The Arg16Gly A>G, Leu134Leu G>A, and Arg175Arg C>A SNPs and haplotype 1 [TTACGC] were significantly associated with specific IgE antibodies to the TDI-human serum albumin (HSA) conjugate in TDI-exposed subjects (P<0.05). Exposed workers with the ADRB2 ht1/ht1 homozygote had a significantly higher TDI-HSA conjugate-specific IgE sensitization rate than did those with the null ht1 haplotype (odds ratio, 15.40; 95% confidence interval, 1.81-131.06). ADRB2 polymorphisms may affect IgE-specific sensitization to TDI-HSA conjugate in TDI-exposed workers.
    Allergy, asthma & immunology research 10/2010; 2(4):260-6. DOI:10.4168/aair.2010.2.4.260 · 3.08 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Occupational exposures are thought to be responsible for 10-15% of new-onset asthma cases in adults, with disparities across sectors. Because most of the data are derived from registries and cross-sectional studies, little is known about incidence of occupational asthma (OA) during the first years after inception of exposure. This paper describes the design of a study that focuses on this early asthma onset period among young workers in the bakery, pastry making and hairdressing sectors in order to assess early incidence of OA in these "at risk" occupations according to exposure duration, and to identify risk factors of OA incidence. The study population is composed of subjects who graduated between 2001 and 2006 in these sectors where they experience exposure to organic or inorganic allergenic or irritant compounds (with an objective of 150 subjects by year) and 250 young workers with no specific occupational exposure. A phone interview focusing on respiratory and 'Ear-Nose-Throat' (ENT) work-related symptoms screen subjects considered as "possibly OA cases". Subjects are invited to participate in a medical visit to complete clinical and lung function investigations, including fractional exhaled nitric oxide (FENO) and carbon monoxide (CO) measurements, and to collect blood samples for IgE (Immunoglobulin E) measurements (total IgE and IgE for work-related and common allergens). Markers of oxidative stress and genetic polymorphisms exploration are also assessed. A random sample of 200 "non-cases" (controls) is also visited, following a nested case-control design. This study may allow to describ a latent period between inception of exposure and the rise of the prevalence of asthma symptoms, an information that would be useful for the prevention of OA. Such a time frame would be suited for conducting screening campaigns of this emergent asthma at a stage when occupational hygiene measures and adapted therapeutic interventions might be effective. Clinical trial registration number is NCT01096537.
    BMC Public Health 04/2010; 10:206. DOI:10.1186/1471-2458-10-206 · 2.32 Impact Factor
Show more

Preview

Download
0 Downloads
Available from